1. Home
  2. WNW vs QTTB Comparison

WNW vs QTTB Comparison

Compare WNW & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WNW
  • QTTB
  • Stock Information
  • Founded
  • WNW 2015
  • QTTB 2015
  • Country
  • WNW China
  • QTTB United States
  • Employees
  • WNW N/A
  • QTTB N/A
  • Industry
  • WNW Catalog/Specialty Distribution
  • QTTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • WNW Consumer Discretionary
  • QTTB Health Care
  • Exchange
  • WNW Nasdaq
  • QTTB Nasdaq
  • Market Cap
  • WNW 26.6M
  • QTTB 23.3M
  • IPO Year
  • WNW 2020
  • QTTB N/A
  • Fundamental
  • Price
  • WNW $1.58
  • QTTB $2.27
  • Analyst Decision
  • WNW
  • QTTB Hold
  • Analyst Count
  • WNW 0
  • QTTB 7
  • Target Price
  • WNW N/A
  • QTTB $12.17
  • AVG Volume (30 Days)
  • WNW 15.0K
  • QTTB 212.5K
  • Earning Date
  • WNW 12-04-2025
  • QTTB 11-07-2025
  • Dividend Yield
  • WNW N/A
  • QTTB N/A
  • EPS Growth
  • WNW N/A
  • QTTB N/A
  • EPS
  • WNW 0.26
  • QTTB N/A
  • Revenue
  • WNW $2,550,178.00
  • QTTB N/A
  • Revenue This Year
  • WNW N/A
  • QTTB N/A
  • Revenue Next Year
  • WNW N/A
  • QTTB N/A
  • P/E Ratio
  • WNW $6.32
  • QTTB N/A
  • Revenue Growth
  • WNW N/A
  • QTTB N/A
  • 52 Week Low
  • WNW $0.95
  • QTTB $1.35
  • 52 Week High
  • WNW $70.00
  • QTTB $51.26
  • Technical
  • Relative Strength Index (RSI)
  • WNW 37.83
  • QTTB 40.57
  • Support Level
  • WNW $1.45
  • QTTB $2.50
  • Resistance Level
  • WNW $1.77
  • QTTB $2.61
  • Average True Range (ATR)
  • WNW 0.14
  • QTTB 0.31
  • MACD
  • WNW -0.02
  • QTTB -0.12
  • Stochastic Oscillator
  • WNW 26.50
  • QTTB 8.28

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Share on Social Networks: